Trials / Completed
CompletedNCT02198391
Study of Echinaforce Junior Tablets in Children With Acute Colds
Multicenter Open-label, Randomized Clinical Trial to Assess the Safety and Efficacy of Echinaforce® Junior Tablets in Two Dosages for the Therapy of Common Cold Symptoms in Children (4-12 Years)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- A. Vogel AG · Industry
- Sex
- All
- Age
- 4 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
This study aims to investigate safety and efficacy of Echinaforce Junior tablets in two dosages of 3 x 1 and 5 x 1 tablets per day in children 4 - 12 years old with acute colds.
Conditions
Timeline
- Start date
- 2014-10-15
- Primary completion
- 2015-08-07
- Completion
- 2015-08-07
- First posted
- 2014-07-23
- Last updated
- 2021-05-04
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02198391. Inclusion in this directory is not an endorsement.